Berriochoa, Camille A <br/><br/>
Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection.  [electronic resource] 

 -  Journal of digestive diseases  Nov 2017 
 - 642-649 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1751-2980 
<br/><br/><label>Standard No.: </label>10.1111/1751-2980.12551  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy, Adjuvant<br/>Deoxycytidine--administration & dosage<br/>Dose Fractionation, Radiation<br/>Drug Combinations<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Irinotecan<br/>Leucovorin--therapeutic use<br/>Lymph Node Excision<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Male<br/>Margins of Excision<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm, Residual<br/>Organometallic Compounds--therapeutic use<br/>Organoplatinum Compounds--therapeutic use<br/>Oxaliplatin<br/>Pancreatectomy<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Radiotherapy, Intensity-Modulated<br/>Retrospective Studies<br/>Survival Rate<br/>Tomography, X-Ray Computed<br/>Tumor Burden--drug effects<br/>Gemcitabine